Fifth Third Bancorp
FLGT icon

Fifth Third Bancorp’s Fulgent Genetics FLGT Stock Holding History

Fifth Third Bancorp’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.41K Sell
215
-25
-10% -$424 ﹤0.01% 3954
2026
Q1 		$3.82K Buy
+240
New +$5.21K ﹤0.01% 3927
2025
Q2 		– Sell
-75
Closed -$1.27K – 2587
2025
Q1 		$1.27K Sell
75
-3
-4% -$51 ﹤0.01% 2375
2024
Q4 		$1.44K Sell
78
-268
-77% -$5.23K ﹤0.01% 2362
2024
Q3 		$7.52K Buy
346
+25
+8% +$559 ﹤0.01% 2085
2024
Q2 		$6.3K Buy
+321
New +$6.7K ﹤0.01% 2059
2024
Q1 		– Sell
-127
Closed -$3.67K – 2425
2023
Q4 		$3.67K Buy
127
+11
+9% +$294 ﹤0.01% 2259
2023
Q3 		$3.1K Sell
116
-6
-5% -$205 ﹤0.01% 2291
2023
Q2 		$4.52K Sell
122
-86
-41% -$3K ﹤0.01% 2225
2023
Q1 		$6.49K Buy
208
+180
+643% +$5.79K ﹤0.01% 2247
2022
Q4 		$834 Buy
+28
New +$1K ﹤0.01% 2556
2022
Q3 		– Sell
-43
Closed -$2K – 2671
2022
Q2 		$2K Sell
43
-11
-20% -$605 ﹤0.01% 2431
2022
Q1 		$3K Buy
54
+17
+46% +$1.12K ﹤0.01% 2436
2021
Q4 		$4K Buy
37
+16
+76% +$1.41K ﹤0.01% 2403
2021
Q3 		$2K Buy
+21
New +$1.91K ﹤0.01% 2447

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fifth Third Bancorp's FLGT Position: Q2 2026 in Review

Fifth Third Bancorp reduced its Fulgent Genetics (FLGT) stake by 10% in Q2 2026, selling an estimated $424 and leaving 215 shares worth $4.41K. The position accounts for ﹤0.01% of the portfolio, ranked #3954.

Fifth Third Bancorp first reported a position in FLGT in Q3 2021 and has held it in 15 quarters since. The position peaked at $7.52K in Q3 2024. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Fifth Third Bancorp held 215 shares of Fulgent Genetics worth $4.41K as of Q2 2026.
  • Fifth Third Bancorp sold 25 Fulgent Genetics shares in Q2 2026, an estimated $424.
  • Fulgent Genetics made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #3954 holding.
  • Fifth Third Bancorp first reported a position in Fulgent Genetics in Q3 2021 and has held it in 15 quarters since.
  • Fifth Third Bancorp's Fulgent Genetics position peaked at $7.52K in Q3 2024.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.